Health - Cancer latest news

ORLANDO, FL (UroToday.com) - (Reported from the Annual Meeting of the American Urological Association) Most of the abstracts suggested that robotic surgery is as effective as open or laparoscopic surgery regarding oncological and functional outcomes. Casey et.al., suggested that a laparoscopic cystectomy was more cost effective than open cystectomy, in part due to not needing the patient to stay in the ICU after robotic cystectomy.

The number of people surviving some of the most common types of cancer for at least five years has doubled since the National health Service was founded 60 years ago. Comparisons have shown that survival for colon cancer has risen dramatically from 18 per cent to 47 per cent while breast cancer survival has more than doubled from 37 per cent to 77 per cent between 1946 and 1998.

Cervical cancer screening needs to take into account a partially-vaccinated population and new technologies, according to an editorial published in the latest edition of Medical Journal of Australia. Dr Annabelle Farnsworth, from Douglass Hanly Moir Pathology, said that although Australia has an enviable record in the control of cervical cancer, there are real benefits in incorporating new knowledge and associated technologies into screening and management of the disease.

(European Society for Medical Oncology) Counting the number of tumor cells circulating in the bloodstream of patients with castration-resistant prostate cancer can accurately predict how well they are responding to treatment, new results show.At the ESMO Conference Lugano organized by the European Society for Medical Oncology, researchers showed that changes in the number of circulating tumor cells predicted the outcome after chemotherapy in this hard to treat cancer.

(European Society for Medical Oncology) Men who develop breast cancer are often not treated until the disease has spread to the point that treatment becomes difficult, new results show. Although most breast cancer patients are women, men make up roughly 1 percent of cases, Dr. Marina Garassino from the Orion Collaborative Group reports at the ESMO Conference Lugano, organized by the European Society for Medical Oncology.

(European Society for Medical Oncology) Preliminary results suggest that patients with aggressive non-Hodgkin's lymphoma in the developing world might benefit from a modified chemotherapy regimen, researchers say.

ORLANDO, FL (UroToday.com) - (Reported from the Annual Meeting of the American Urological Association) The main thrust of the presentations concerned decreasing the radiographic screening burden of patients with testis cancer. Chamin, et al, used SEER data to evaluate the risk of secondary malignancy in men with testis cancer who did or did not have a RPLND. After 14 yrs follow-up, men on a surveillance protocol for their testis cancer had a 1.

American cancer Society - Researchers at Massachusetts General hospital (MGH) are testing a non-surgical technique that may help doctors monitor how well non-small cell lung cancer patients are responding to treatment. Using a device known as a CTC-chip to analyze circulating tumor cells from patients' blood samples, the scientists were able to identify whether patients had genetic mutations that would make them less likely to respond to certain therapies.